The conjugation of an anti-human epidermal growth factor receptor antibody (anti-EGFR) to the ALPs induced EGFR-mediated uptake into non-small cell lung cancer cell lines, but not into NIH-3 T3 cells that do not have the receptor [77]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.